EZH2 and diffuse large B-cell lymphoma: Both BCL2 immunoexpression and EZH2/BCL2 co-expression were more frequent in HGBCL–DH/TH when compared to DLBCL-NOS (100% vs. 54%, p = 0.025 and 50% vs. 10%, p = 0.004, respectively).